Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H17NO3 |
| Molecular Weight | 247.2897 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N1CCCCC1)C2=CC3=C(OCCO3)C=C2
InChI
InChIKey=LJUNPHMOGNFFOS-UHFFFAOYSA-N
InChI=1S/C14H17NO3/c16-14(15-6-2-1-3-7-15)11-4-5-12-13(10-11)18-9-8-17-12/h4-5,10H,1-3,6-9H2
| Molecular Formula | C14H17NO3 |
| Molecular Weight | 247.2897 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2096670 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11640919 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| AMPA receptor mediates mGlu 2/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell. | 2010-11 |
|
| Effects of agents targeting glutamatergic systems on marble-burying behavior. | 2010-03-03 |
|
| Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats. | 2010-02-11 |
|
| Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations. | 2009-12 |
|
| Memory and the NMDA receptors. | 2009-07-16 |
|
| Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning. | 2009-02-24 |
|
| Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network. | 2008-12-10 |
|
| Central respiratory rhythmogenesis is abnormal in lbx1- deficient mice. | 2008-10-22 |
|
| Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats. | 2007-12-01 |
|
| Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. | 2007-10-03 |
|
| The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice. | 2007-04 |
|
| Ampakines alleviate respiratory depression in rats. | 2006-12-15 |
|
| Glutamate-based therapeutic approaches: ampakines. | 2006-02 |
|
| Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus. | 2005-04 |
|
| Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators. | 2005-02 |
|
| Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus. | 2004 |
|
| Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization. | 2003-07 |
|
| Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion. | 2003 |
|
| Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism. | 2003 |
|
| Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. | 2002-12 |
|
| A remote-controlled high pressure reactor for radiotracer synthesis with [11C]carbon monoxide. | 2002-11 |
|
| Survival signaling and selective neuroprotection through glutamatergic transmission. | 2002-03 |
|
| Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. | 2001-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:38:18 GMT 2025
by
admin
on
Mon Mar 31 18:38:18 GMT 2025
|
| Record UNII |
PV6YEC8983
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
215923-54-9
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY | |||
|
CX546
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY | |||
|
2890
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY | |||
|
DTXSID70175951
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY | |||
|
PV6YEC8983
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY | |||
|
C443080
Created by
admin on Mon Mar 31 18:38:18 GMT 2025 , Edited by admin on Mon Mar 31 18:38:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->POSITIVE ALLOSTERIC MODULATOR (PAM) |
Low-impact AMPAR PAMs decrease AMPAR deactivation (channel closing) alone to augment synaptic currents
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |